2-(N-morpholino)ethanesulfonic acid

Apreo Health emerges from stealth to present first-in-human data for its BREATHE Airway Scaffold, a tissue-sparing implant designed to relieve pressure in hyperinflated lungs without sacrificing healthy tissue.

Personalis and academic collaborators will showcase new clinical data on their ultrasensitive NeXT Personal ctDNA assay at upcoming AACR and ASCO conferences, demonstrating its application across multiple cancer types.

The pivotal Phase 3 REVERSE-IT trial demonstrated that bentracimab rapidly restored platelet function within 5-10 minutes in patients on ticagrelor requiring urgent surgery or experiencing major bleeding.

Phase 3 STRIDE trial results show Ozempic (semaglutide) 1 mg increased maximum walking distance by 13% compared to placebo in patients with type 2 diabetes and peripheral artery disease.

Phase 2 SECOMBIT and Phase 3 DREAMseq trials demonstrate superior overall survival when initiating treatment with immune checkpoint inhibitors versus targeted therapy in BRAF-mutant melanoma patients.